William G. Richards

Brigham and Women's Hospital — United States

Medicine · Health Sciences

96h-index68.5kcitations526works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Occupational and environmental lung diseases(146), Medical Imaging and Pathology Studies(103), Pleural and Pulmonary Diseases(61), Lung Cancer Treatments and Mutations(38), Cancer Immunotherapy and Biomarkers(31)

Publications474 total

Candidate biomarkers to identify mesothelioma patients at risk of developing venous thromboembolism post-surgery
Scientific Reports·2026Open Access
Multiomic, Histologic, and scRNA-seq Profiling of Pleural Mesothelioma Reveals Negative Prognosis Associated With a Novel Uncommitted Molecular Phenotype
Journal of Thoracic Oncology·2025· 1 citedOpen Access
Recurrence Patterns and Management after Pleurectomy Decortication for Pleural Mesothelioma
Annals of Surgery·2025· 1 citedOpen Access
Characteristics of Long-term Survivors With Malignant Pleural Mesothelioma
The Annals of Thoracic Surgery·2024· 3 cited
Loom: A Modular Open-Source Approach to Rapidly Produce Sensor, Actuator, Datalogger Systems
Sensors·2024· 2 citedOpen Access
Comprehensive multi-site profiling of the malignant pleural mesothelioma micro-environment identifies candidate molecular determinants of histopathologic type
2024· 2 citedOpen Access
Predictive potential of MRI in differentiating the predominant component in biphasic pleural mesothelioma
European Journal of Radiology·2024Open Access
Circulating <scp>SMRP</scp> and <scp>CA</scp>‐125 before and after pleurectomy decortication for pleural mesothelioma
Thoracic Cancer·2024· 5 citedOpen Access
Online Tool Selection with Learned Grasp Prediction Models
2023· 3 cited
Mo1265 TARTETING VENTX-MEDIATED IMMUNE SUPPRESSION IN TUMOR MICROENVIRONMENT TO ENHANCE EFFICACY OF GEMCITABINE AGAINST PANCRETIC CANCER
Gastroenterology·2023
Abstract 5111: VentX-modulated tumor associated macrophages revert immune suppression in tumor microenvironment and promote efficacy of gemcitabine against pancreatic cancer
Cancer Research·2023
Supplementary Data from Activation of Tumor-Cell STING Primes NK-Cell Therapy
2023Open Access
Data from Activation of Tumor-Cell STING Primes NK-Cell Therapy
2023Open Access
Data from Activation of Tumor-Cell STING Primes NK-Cell Therapy
2023· 1 citedOpen Access
Abstract 95: Uncommitted cells and phenotypic plasticity elucidate the complexity of the epithelial-mesenchymal molecular gradient of pleural mesothelioma
Cancer Research·2023
Supplementary Data from Activation of Tumor-Cell STING Primes NK-Cell Therapy
2023Open Access
Supplementary Figure S2 from Metabolic Profiling of Formalin-Fixed Paraffin-Embedded Tissues Discriminates Normal Colon from Colorectal Cancer
2023Open Access
Table S3 from &lt;i&gt;Ex Vivo&lt;/i&gt; Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
2023Open Access
Supplementary Data from &lt;i&gt;Ex Vivo&lt;/i&gt; Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
2023Open Access
Data from CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
2023Open Access
page 1 of 24Next →

Frequent Co-authors

David J. Sugarbaker(26), Raphael Bueno(13), Michael T. Jaklitsch(7), Matthew Meyerson(6), Steven Swanson(6), Steven J. Mentzer(6), Pasi A. Jänne(5), Kwok‐Kin Wong(5), Michael S. Ominsky(5), Katsuhiko Naoki(5), Bruce E. Johnson(4), Raphael Bueno(4), Gary M. Strauss(4), Lucian R. Chirieac(4), Gavin J. Gordon(4), Roderick V. Jensen(4), Xiaodong Li(4), Sangeetha Palakurthi(3), Gordon J. Freeman(3), Assunta De Rienzo(3)